Incidence and Predictors of Sars-Cov-2 Antibody Responses Following COVID-19 Vaccination in Allogeneic Stem Cell Transplant Recipients

Background Pharmacologic immunosuppression and incomplete immune reconstitution after allogeneic stem cell transplant (alloSCT) may impair a patient's ability to mount an immune response to vaccines, including currently available COVID-19 vaccines. Since immunocompromised patients are susceptib...

Descripción completa

Detalles Bibliográficos
Autores principales: Minehart, Janna C., Catania, Christopher, Perry, Linda, Martin, Mary Ellen, Smith, Jacqueline, McCurdy, Shannon R., Pratz, Keith W., Luger, Selina M., Timlin, Colleen, Perl, Alexander E., Schuster, Mindy, Porter, David L, Loren, Alison W., Hexner, Elizabeth O., Frey, Noelle V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701570/
http://dx.doi.org/10.1182/blood-2021-153920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701570/
http://dx.doi.org/10.1182/blood-2021-153920

Ejemplares similares